Publication Date: 1/6/2010
Novolog® (insulin aspart) is available in both Europe and the USA. It is a synthetic rapid-lasting insulin product.
Insulin aspart
- Brand name in US: Novolog®
- Brand name in Europe: NovoRapid®
- Class: insulin analog
- For: insulin-treated diabetes
- Route of Administration: subcutaneous
- Action: short-acting insulin
- manufacturer: Novo Nordisk Pharmaceuticals
- Other drugs with approximately the same duration of action: Insulin glulisine (Apidra®), Insulin lispro (Humalog®).
